← Markets

Columbia Small Cap Value and Inflection Fund;A

COVAX · NASDAQ

Market closed$15.30$-0.150000 (-0.97%)

Key statistics

Previous close$15.45
Open$15.30
Day high$15.30
Day low$15.30
52-week high$15.64
52-week low$12.75
Market cap910.74M
Volume—
Average volume—
P/E ratio16.60
Forward P/E—
EPS0.92
Dividend yield0.00%

Market context

Why it moved

COVAX shares declined modestly as broader sentiment around global vaccine distribution initiatives remained subdued, with no major new funding commitments or procurement deals announced to reinvigorate investor confidence in the program.

WikipediaMedicircleAcEspnFrontiersin

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026Columbia Small Cap Value and Inflection Fund edged higher, supported by a broadly constructive backdrop for financial sector assets amid a robust Q2 earnings season for Wall Street. Finance sector earnings are tracking +30.2% year-over-year, with major banks beating estimates handily, lifting sentiment across asset managers. However, the fund's small-cap value focus faces a nuanced environment: AI-driven market concentration has left many non-AI stocks moving independently of the broader index, with Morningstar noting financial services underperformed in Q2 and flagging AI disruption concerns and private credit cracks as headwinds for the sector.

0.857

July 15, 2026Columbia Small Cap Value and Inflection Fund (COVAX) closed up 1%, benefiting from a broadly constructive session for financial services as Wall Street bank earnings dominated headlines. BlackRock topped Q2 estimates with record iShares inflows surpassing $6 trillion in AUM, while Goldman Sachs, JPMorgan, Morgan Stanley, and Citigroup all posted strong results fueled by record trading and dealmaking activity. The positive financials backdrop and softer-than-expected June CPI data — which eased rate-hike fears — supported the XLF sector ETF near its 52-week high, providing a favorable tailwind for small-cap value-oriented equity strategies. However, Natixis strategists note that 76% expect large-caps to outperform small-caps in H2 2026, and the broader rotation away from value toward AI-driven growth themes remains a headwind for small-cap value funds like COVAX.

0.9987

July 14, 2026Columbia Small Cap Value and Inflection Fund (COVAX) edged modestly higher, closing up 0.33%, as the broader financial services sector navigated a busy Q2 earnings backdrop. Major Wall Street banks—JPMorgan, Goldman Sachs, and Wells Fargo—all posted strong results driven by record trading revenue and surging M&A activity, providing a constructive backdrop for asset managers. However, Morningstar flagged that financial stocks underperformed the broader market in Q2, citing concerns over AI disruption in financial services and cracks in private credit. Meanwhile, a softer-than-expected June CPI print of 3.5% helped lift equities off recent lows, even as Iran-related geopolitical tensions and rising oil prices kept investor sentiment cautious.

0.3329

July 9, 2026Columbia Small Cap Value and Inflection Fund (COVAX) closed essentially unchanged, holding near the $14.98 level as broader financial services stocks navigated a volatile macro backdrop. Geopolitical tensions from renewed U.S.-Iran exchanges dominated sentiment, driving oil prices sharply higher and rekindling inflation fears that weighed on rate-sensitive assets. With small-cap value stocks broadly caught between the crosscurrents of a strengthening dollar, rising Treasury yields, and an upcoming Q2 earnings season for major financials—set to kick off July 14 with JPMorgan and peers—investors are closely watching whether the broadening market theme that lifted small- and mid-cap stocks in June can hold amid persistent geopolitical uncertainty.

-0.1999

June 30, 2026Columbia Small Cap Value and Inflection Fund (COVAX) edged lower on the final trading day of the first half of 2026, as the broader financial services sector faced headwinds. Oppenheimer downgraded major investment banks including Goldman Sachs and Morgan Stanley to underperform, weighing on financial sector sentiment, while the XLF sector ETF also slipped modestly in after-hours trading. Despite a strong quarter for U.S. equities overall — driven by AI optimism and geopolitical de-escalation between the U.S. and Iran — small-cap value funds like COVAX navigated a mixed environment as investors favored large-cap tech on the final half-year session.

-0.6588

Peers

S&P 500SPX · $7,457.69-1.01%Artisan Mid Cap Value FundAPHQX · $15.76-0.76%American Century Global Real Estate Fd Inv ClARYVX · $15.29+0.26%Brandes Emerging Markets Value Fund Class IBEMIX · $14.45-0.69%CLARKSTON FOUNDERS FUND, Institutional ClassCIMDX · $17.05-1.33%Diamond Hill Small Mid Cap Fund Class IDHMIX · $28.38-0.56%BNY Mellon Small Cap Stock Index Fund Investor SharesDISSX · $26.99-0.70%Putnam International Equity Fd Class APOVSX · $33.51-0.80%T. Rowe Price Integrated US SMCC EqTQSMX · $29.73-0.50%Value Line Small Cap Opportunities Fund, Inc. Investor ClassVLEOX · $65.21-0.75%Westwood Quality SmallCap Fund Institutional ClassWHGSX · $22.18-0.81%